What if they gave a “cure for cancer party” and the US didn’t come? That is, basically, what is happening, in Canada and elsewhere in the world, right now.
Once again, the US Federal Drug Administration (FDA) has turned its back on the best interests of Us the People, in favor of reaping enormous profits.
The FDA is a regulatory agency of the United States Department of Health and Human Services for ensuring that most types of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics are safe for consumers to use.
Whenever new medical technology or products are developed, they must pass FDA approval before the patent owners – often a drug company – begins to manufacture, distribute and sell their highly marked-up wares.
Wikipedia says that “Numerous governmental and non-governmental organizations have criticized the U. S. Food and Drug Administration for alleged excessive and/or insufficient regulation.” No kidding. There are far too many FDA submissions for approval than the federal organization entrusted with this duty can handle.
Jessica Wapner blogged, in 2012: “The FDA said that without more money, there would never be enough staff support to churn out approvals at a rate that met with public and industry approval, and that met the needs of patients awaiting better treatments.”
What’s a federal agency to do? PASS ANOTHER LAW! Yes, that’s right. In 1992, the Prescription Drug User Fee Act was enacted to address complaints from consumers, the pharmaceutical industry and the FDA itself that drug approvals were taking too long.
Unfortunately, and ironically, PDUFA has created unwanted side effects, in the same way as the drugs covered by this legislation. Drugs companies have actually been found to have offered pay-offs (read: bribes) to FDA staffers in order to expedite their drug’s approval.
This practice has become Very Big Business for the FDA: in 2010, the grand total of PDUFA fees collected in was $529,276,543.
But you’d better be sitting down before you read this next shocker. An Avalere article reports [bolding added]:
“Since 1992, the Food and Drug Administration (FDA) has collected $7.67 billion in user fees from pharmaceutical manufacturers to fund drug reviews based on an Avalere analysis of FDA data.”
That’s over 7 BILLION (a thousand million) dollars. There is no question that the FDA is used to enjoying a lot of power and a lot of money. But are they really helping improve the health of the nation’s citizenry – or do they just pay lip service to the notion of “cure” since the bigger profits lie in perpetual treatment?
Case in point: you’ve probably seen those pink ribbons that represent the Fight Against Breast Cancer. You may know someone who has participated in a sponsorship “Race for the Cure” to raise money to find the elusive cure for this high-profile killer.
Dr. Mercola informs us that “nearly two million Americans are diagnosed with cancer every year—one person out of three will be hit with a cancer diagnosis at some time in their lives, in spite of the massive technological advances over the past half-century.”
Well, turns out you can run as fast as humanly possible and still get nowhere. The FDA is a hurdle so big and vast that it is insurmountable.
Trending in the news now is Canadian Dr. Evangelos Michelakis and his research team at the University of Alberta. According to this YouTube video, Dr. Michelakis’ team has been able to shrink cancerous tumors in rats by administering an inexpensive powder called DCA (Dichloroacetate). DCA has been around for years, and tested successfully on humans in other drug compounds.
Reaching Utopia adds this remarkable characteristic of DCA:
“The drug, dichloroacetate (DCA) can alter the metabolism of cancer cells and thus causes them to age and be destroyed. It’s important to note that it kills the cancer cells but only the bad ones.”
Because DCA does not have a patent, anyone can manufacture it without paying a fee to the FDA. Plus, because it is so cheap – pennies a dose – that its sale would not be profitable.
Do you remember, two years ago, when Martin Shkreli raised drug prices from $13.50 to $750, an increase of 5,500 percent?
Apparently, ripping off the American public is an Industry Best Practice now, among pharmaceutical companies. Valeant Pharmaceuticals has been accused of raising drug prices by more than 5,000 percent. Another money-grubbing company identified by the Gizmodo was profiled earlier this month:
“Avondale Pharmaceuticals raised the price of Niacor, a prescription-only version of niacin [a VITAMIN], by 809 per cent last month, taking a bottle of 100 tablets from $32.46 to $295.”
Profits like these make the 10% average gain for the Dow Jones Industrial Average (DJIA) pale in comparison. Frankly, there is no comparison.
The FDA and its dependent Big Pharma spawn have set themselves up to run the business of national health treatment – and cure – as they see fit.
Never forget that all corporations are accountable to their shareholders (people who own stock, bonds, or have some other stake in the company’s success, as defined by profit or loss).
Periodic fiscal accountability is a condition inherent to a capitalistic economic system like ours. Yet, if healthcare warrants national administration (think: Obamacare), then don’t consumers deserve some protection from price rigging and FDA refusal to approve cures for terminal illnesses like cancer?
By the way, other doctors have been treating cancer with strong positive results. Notable among them is Dr. Stanislaw Burzynski whose practice is in Texas. For decades now, the FDA has been persecuting this noble doctor, despite courtroom testimony that his treatments actually did cure cancer, even in “hopeless cases.”
Dear Readers, it is difficult to write this, but there will be NO CURE FOR CANCER IN THE UNITED STATES unless or until the FDA rearranges their priorities, away from greed and toward genuine need.
Don’t hold your breath for that to happen. You might turn blue in the face and fall down. Fortunately, the FDA has approved treatment for that.